Antares Pharma, Inc. Reports Third Quarter 2012 Financial and Operating Results
Published: Nov 07, 2012
Quarter and Recent Highlights
Completed all clinical studies for the VIBEX™ MTX Medi-Jet™ product ahead of schedule including a recently completed clinical pharmacokinetic study, an actual human use study and a human factors usability study. The NDA remains on track for a Q1 2013 filing.